tert-butyl 3-{[(4-chlorophenyl)methyl]amino}-2-methylpropanoate, 95.0%, 2g

Ethyl 2-methyl-3-oxo-3-phenylpropanoate, 95.0%, 5g

Diphenylamine, min. 99%, pa, ACS, 500 g, glass packaging

4-Hydroxy-2-nitroaniline, 95.0%, 25g

N-(3,4-Dichlorophenyl)-7-methoxy-6-nitroquinazolin-4-amine (Dacomitinib Impurity), 98%, 50mg

(S)-2-(Trifluoromethyl)morpholine hydrochloride, 97%, 250mg

2,2-Dimethyl-4-oxo-3,8,11,14,17,20,23,26,29-nonaoxa-5-azadotriacontan-32-oic acid, 95%, 100mg

4,4',4''-TRI-TERT-BUTYL-2,2':6',2''-TERPYRIDINE, 96%, 5g

(4-(N-Cyclohexylsulfamoyl)phenyl)boronic acid, 97%, 250mg

(1-PHENYL-1H-PYRAZOL-4-YL)METHANOL, 97.0%, 250mg

Methanesulfonylmethane, 99.0%, 1kg

Orotic acid monohydrate, 95.0%, 25g

1-Allyl-3-methylimidazolium Chloride>98.0%(HPLC)(T)5g